Concepedia
Statistics
Publications
6
Citations
733
H-Index
Active since
2019
Affiliations
NYU Langone Health(Current)
Dana-Farber Cancer Institute
New York University
Harvard University
Brigham and Women's Hospital
Val Pyon is an author at NYU Langone Health specializing in oncology, molecular oncology, and immune checkpoint regulation.
Publications per year
2019–2021
CDK7 Inhibition Potentiates Genome Instability Triggering Anti-tumor Immunity in Small Cell Lung Cancer
Hua Zhang, Camilla L. Christensen, Ruben Dries et al. · Cancer Cell · 2019 · 224 citations · Full text
Medicine, Cancer Biology, Oncology +12
<i>In Vivo</i> Epigenetic CRISPR Screen Identifies <i>Asf1a</i> as an Immunotherapeutic Target in <i>Kras</i> -Mutant Lung Adenocarcinoma
Fei Li, Qingyuan Huang, Troy A. Luster et al. · Cancer Discovery · 2019 · 208 citations · Full text
Life Sciences, Immunology, Oncology +17
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer
Jiehui Deng, Aatish Thennavan, Igor Dolgalev et al. · Nature Cancer · 2021 · 140 citations · Full text
Medicine, Cancer Biology, Oncology +13
Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
Josephine Hai, Hua Zhang, Jin Zhou et al. · Clinical Cancer Research · 2020 · 74 citations · Full text
Targeting <i>HER2</i> Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib
Han Han, Shuai Li, Ting Chen et al. · Cancer Research · 2021 · 57 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 6